Iovance Biotherapeutics Grants Stock Options to 21 New Employees
Iovance Biotherapeutics, Inc. (IOVA) approved equity inducement awards covering a total of 111,615 shares of common stock to 21 newly hired non-executive employees. The grants were approved on October 15, 2026, under the company's 2021 Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
Each stock option carries an exercise price of $14.72 per share, which matches the closing price of the company's common stock on the grant date. The options vest over a three-year period, with one-third vesting on the first anniversary of the employee's start date and the remaining two-thirds vesting in eight equal quarterly installments over the following two years. Shares of the biotechnology company closed down 7.47% at $13.62 on October 16, 2026.
Inducement grants are standard equity compensation tools used by publicly traded companies to attract new personnel without needing prior shareholder approval. Investors will monitor how the company continues to build its team as it advances its cancer therapy programs and expands commercial operations.
Key points
- Iovance Biotherapeutics granted 111,615 stock options to 21 new non-executive employees.
- The options feature an exercise price of $14.72 per share, matching the closing price on October 15, 2026.
- Awards vest over three years, with one-third vesting on the first anniversary and the rest quarterly over two years.
- The grants were issued under Nasdaq Listing Rule 5635(c)(4) as an inducement to enter employment.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
What are the details of the Iovance Biotherapeutics stock option grants?
Iovance Biotherapeutics granted stock options covering 111,615 shares to 21 new non-executive employees with an exercise price of $14.72 per share.
What is the vesting schedule for the Iovance equity awards?
The options vest over three years, with one-third vesting after one year of employment and the remaining two-thirds vesting in eight quarterly installments over the following two years.